Coherus Oncology, Inc. Common Stock
CHRS
CHRS
109 hedge funds and large institutions have $1.05B invested in Coherus Oncology, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
-6
Holders Change %
-5.22%
% of All Funds
2.5%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
8
Increased
49
Reduced
40
Closed
14
Calls
$4.84M
Puts
$5.65M
Net Calls
-$815K
Net Calls Change
-$6.21M
Top Buyers
| 1 |
HP
Hound Partners
New York
|
$33.2M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$31.8M |
| 3 |
BlackRock
New York
|
$76.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$44.3M |
| 5 |
PC
Pier Capital
Stamford,
Connecticut
|
$10.5M |
